Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

BACKGROUND: Our objective was to determine if previously reported overall survival (OS) and progression-free survival (PFS) rates are maintained long term following multimodal therapy for advanced and recurrent endometrial cancer and to assess the lymphedema rates associated with this therapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Glasgow, Michelle, Vogel, Rachel Isaksson, Burgart, Jennifer, Argenta, Peter, Dusenbery, Kathryn, Geller, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940984/
https://www.ncbi.nlm.nih.gov/pubmed/27408749
http://dx.doi.org/10.1186/s40661-016-0027-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940984/
https://www.ncbi.nlm.nih.gov/pubmed/27408749
http://dx.doi.org/10.1186/s40661-016-0027-4

Ejemplares similares